⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 15, 2024Open Access

Supplementary Figure 2 from Cervicovaginal Metabolome and Tumor Characteristics for Endometrial Cancer Detection and Risk Stratification

Georgia M. Lorentzen Paweł Łaniewski Haiyan Cui Nichole D. Mahnert Jamal Mourad Matthew P. Borst Lyndsay Willmott Dana M. Chase Denise J. Roe Melissa M. Herbst‐Kralovetz

View Full Paper

Ask AI

Bookmark

Share

Abstract

Enrichment analysis reveals pathways altered in endometrila cancer vs benign controls. Enrichment analysis is based on the KEGG pathway database. Bar plots show the top 25 enriched pathways in EC All vs benign controls.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lorentzen et al. (2024) studied this question.

synapsesocial.com/papers/68e60477b6db6435875984dd https://doi.org/10.1158/1078-0432.26302679

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 2 from Cervicovaginal Metabolome and Tumor Characteristics for Endometrial Cancer Detection and Risk Stratification2024
2Supplementary Figure 3 from Cervicovaginal Metabolome and Tumor Characteristics for Endometrial Cancer Detection and Risk Stratification2024
3Supplementary Figure 3 from Cervicovaginal Metabolome and Tumor Characteristics for Endometrial Cancer Detection and Risk Stratification2024
4Supplementary Figure1 from Cervicovaginal Metabolome and Tumor Characteristics for Endometrial Cancer Detection and Risk Stratification2024
5Supplementary Figure1 from Cervicovaginal Metabolome and Tumor Characteristics for Endometrial Cancer Detection and Risk Stratification2024